Checkpoint Inhibition Squamous Cell and Nonsquamous Cell NSCLC

Video

Related Videos
Eric Vallieres, MD, FRCSC
Benjamin Levy, MD
Francesco Di Meo, PhD
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Saad J. Kenderian, MB, CHB
Jaime Schneider, MD, PhD
Benjamin Creelan, MD